References
- Thistle J L, Schoenfield L J. Induced alterations in composition of bile of persons having cholelithiasis. Gastroenterology 1971; 61: 488–496
- Danziger R G, Hofmann A F, Schoenfield L J, Thistle J L. Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 1972; 286: 1–8
- Schoenfield L J, Lachin J M. The steering committee and the national co-operative gallstone study group. A controlled trial of the efficacy and safety of chenodeoxycholic acid for dissolution of gallstones. Ann Intern Med 1981; 95: 257–282
- Makino I, Shinozaki K, Yoshino K, Nakagawa S. Dissolution of cholesterol gallstones by ursodeoxycholic acid. Jpn J Gastroenterol 1975; 72: 690–702
- Maton P N, Murphy G M, Dowling R H. Ursodeoxycholic acid treatment of gallstones. Dose response study and possible mechanism of action. Lancet 1977; 2: 1297–1301
- Erlinger S, Go A L, Hussen J M, Fervery J. Franco-Belgium co-operative study of ursodeoxycholic acid in the medical dissolution of gallstones: a double blind randomized, dose-response study, and comparison with chenodeoxycholic acid. Hepatology 1984; 4: 308–314
- Kameda H. for the Tokyo cooperative gallstone study group. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Gastroenterology 1980; 78: 542–548
- Roda E, Bazzoli F, Labate A MN, et al. Ursodeoxycholic acid vs chenodeoxycholic acid as cholesterol gallstone dissolving agents: a comparative randomized study. Hepatology 1982; 2: 804–810
- Fromm H, Roat J N, Gonzalez V, Sarva R J, Farivar S. Comparative efficacy and side effects of ursodeoxycholic acid and chenodeoxycholic acid in dissolving gallstones. Gastroenterology 1983; 85: 1257–1264
- Bachrach W H, Hofmann A F. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. II. Dig Dis Sci 1982; 27: 833–856
- Bateson M C, Bouchier I AD, Trash D B, Maudgal D P, Northfield T C. Calcification of radiolucent gallstones during treatment with ursodeoxycholic acid. Br Med J 1981; 283: 645–646
- Bettini L, Lanzini A, Facchinetti D, Vezzoli G, Remida G F, Muiesan G. Efficacy rate of ursodeoxycholic acid for gallstone dissolution. Recent advances in bile acid research, L Barbara, R H Dowling, A F Hofmann, E Roda. Raven Press, New York 1985; 303–306
- Podda M, Zuin M, Battezzati P M, Ghezzi C, De Fazio C, Dioguardi M L. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone. Gastroenterology 1989; 96: 222–229
- Maudgal D P, Bird R, Northfield T C. Optimal timing of doses of chenic acid in patients with gallstones. Br Med J 1979; 1: 922–923
- Maudgal D P, Kupfer R M, Northfield T C. Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and a low cholesterol diet. Gut 1982; 23: 280–284
- Sama C, Morselli Labate A M, Chidarelli C, Roda A, Briganti M, Roda E. Bioavailability of a delayed-release preparation of ursodeoxycholic acid in man. Curr Ther Res 1983; 33: 558–564
- Lanzini A, Facchinetti D, Northfield T C. Maintenance of hepatic bile acid secretion rate during overnight fasting by bedtime bile acid administration. Gastroenterology 1988; 95: 1029–1035
- Northfield T C, LaRusso N F, Hofmann A F, Thistle J L. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid in gallstone subjects. Gut 1975; 16: 12–17
- Thomas P J, Hofmann A F. A simple calculation of the lithogenic index of bile expressing biliary lipid composition on rectangular coordinates. Gastroenterology 1973; 65: 698–700
- Hegardt F G, Dam H. The solubility of cholesterol in aqueous solutions of bile salts and lecithin. Z Ernaehrungswiss 1971; 10: 223–233
- Corrigan O I, Su C C, Higuchi W I, Hofmann A F. Mesophase formation during cholesterol dissolution in ursodeoxycholate-lecithin solutions: new mechanism for gallstone dissolution in humans. J Pharmacol Sci 1980; 69: 869–871
- Northfield T C, Lanzini A, Jazrawi R P, Maudgal D P, Kupfer R. Methods of improving efficacy of litholytic therapy. Enterohepatic circulation of bile acids and sterol metabolism, G Paumgartner, A Stiehl, W Gerok. MTP Press Limited, Lancaster 1985; 335–350
- Carey M C, Park Y H, Igimi H, Salvioli G. Factors affecting speed of gallstone dissolution during litholytic therapy. Enterohepatic circulation of bile acids and sterol metabolism, G Paumgartner, A Stiehl, W Gerok. MTP Press Limited, Lancaster 1985; 321–331